Compare NOV Inc. Common Stock (NOV) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NOV Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? NOV Inc. Common Stock trades at $19.08 (market cap $6.64B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.8× NOV Inc. Common Stock's market cap, and NOV Inc. Common Stock pays a 1.93% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| NOV | ROIV | |
|---|---|---|
Market Cap | $6.64B | $25.09B |
Volume | 4,238,905 | 5,738,571 |
Sector | Energy | Health |
52-Week High | $21.71 | $41.81 |
52-Week Low | $12.31 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $7.80B | $21.36B |
Dividend Yield | 1.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
